Assert-IQ vs Strain AI
AI Verdict
Choose Assert-IQ if…
Choose Assert-IQ if your primary need is long-term, continuous monitoring for elusive or infrequent cardiac arrhythmias over several years. This system is ideal for patients experiencing intermittent symptoms that are difficult to capture with shorter-term monitoring, providing comprehensive data for diagnosis and ongoing management of suspected heart rhythm disorders.
View Assert-IQ →Choose Strain AI if…
Choose Strain AI if you require real-time, AI-powered quantitative assessment of myocardial function directly from cardiac ultrasound images. This tool is best suited for clinicians needing immediate insights into Global Longitudinal Strain (GLS) to aid in the early detection and management of conditions like heart failure or cardiotoxicity during an echocardiogram.
View Strain AI →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Strain AIStrain AI integrates directly into existing ultrasound workflows, providing real-time, on-device AI insights without an internet connection, which streamlines the diagnostic process for clinicians. Assert-IQ, while offering remote monitoring, requires a minimally invasive insertion procedure and a separate monitoring platform, making its initial setup and ongoing patient interaction more involved.
Clinical Value
Assert-IQAssert-IQ provides long-term, continuous cardiac monitoring for up to 6 years, which is crucial for detecting and managing intermittent or elusive arrhythmias that might be missed by shorter-term diagnostic methods. While Strain AI offers valuable real-time GLS measurements, Assert-IQ's extended, passive data collection offers a broader and more profound clinical impact for chronic rhythm disorders.
Pricing & Value
TieBoth tools require direct contact with the vendor for pricing information, indicating an enterprise sales model. Neither provides transparent pricing details or offers a free trial, making a direct comparison of their cost-effectiveness impossible without further information.
Enterprise Readiness
Assert-IQAbbott Medical, the company behind Assert-IQ, is a global, well-established medical device leader with a long history, suggesting robust enterprise support, sales, and integration capabilities. While Exo's Strain AI is FDA cleared and HIPAA compliant with on-device AI for simplified deployment, Abbott's extensive infrastructure and experience with large-scale health system deployments give it an edge in overall enterprise readiness.
Innovation
Strain AIStrain AI offers significant innovation by applying AI to automate and standardize Global Longitudinal Strain (GLS) measurement from ultrasound images in real-time and on-device, directly at the point of care. This real-time, on-device AI integration into an existing workflow is a disruptive advancement in diagnostic imaging. Assert-IQ's innovation focuses on extending the duration and sophistication of an existing monitoring paradigm.
Support & Docs
Assert-IQAbbott Medical, as a large and long-established global healthcare company, is expected to have a more extensive and mature support infrastructure, comprehensive training programs, and detailed documentation for its products. Assert-IQ's website explicitly offers clinician and patient manuals, remote programming support, and a dedicated remote monitoring support team.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Assert-IQ | Strain AI |
|---|---|---|
| Name | Assert-IQ | Strain AI |
| Company | Abbott Medical | Exo |
| Description | The Assert-IQu2122 Insertable Cardiac Monitor (ICM) system provides long-term, continuous monitoring and advanced arrhythmia detection to aid physicians in diagnosing and managing patients with suspected heart rhythm disorders. | Exo's FDA-cleared Strain AI is an AI-powered medical software that analyzes cardiac ultrasound images to measure Global Longitudinal Strain (GLS), aiding physicians in assessing heart function and detecting conditions like heart failure and cardiotoxicity in adult patients. |
| Key Features | Long-term continuous cardiac monitoring (up to 6 years), Advanced arrhythmia detection algorithms, Bluetoothu00ae Low Energy data transmission, Secure cloud-based data platform, Remote monitoring capabilities, Proactive clinician alerts, Patient activator for symptom logging, Minimally invasive insertion | Analyzes cardiac ultrasound images, Measures Global Longitudinal Strain (GLS), Aids in assessing heart function in adult patients, Integrates with existing ultrasound devices, Provides quantitative strain measurements, Supports diagnostic evaluation without manual image interpretation, Delivers real-time, on-device AI insights, Assists in detecting heart failure (CHF, HFpEF, HFrEF) and hypertrophy |
| Categories | Cardiology AI, Clinical Decision Support & Reference | Cardiology AI, Radiology & Imaging AI |
| Specialties | Cardiology, Internal Medicine | Cardiology, Oncology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring Assert-IQ and Strain AI.